Full Name
Julien Nyombayire
Hospital/Organisation/Company
Center for Family Health Research, Rwanda
Speaker Bio
Dr Nyombayire is a research clinician at the Center for Family Health Research (CFHR) in Rwanda, a long-standing clinical research institution established in Rwanda since 1986 and formerly known as Projet San Francisco. With more than 16 years’ experience in clinical research, Dr Nyombayire has served as an investigator in several observational cohort studies as well as multicenter clinical trials of preventive vaccine and therapeutics in various infectious diseases area including HIV, Ebola, Covid-19 and Malaria. He has recently served as the Principal Investigator for the first ever Phase 1 clinical trial of an mRNA HIV vaccine candidate conducted in Africa and a co-investigator of the first large Phase 3 Ebola vaccine trial among pregnant women in Rwanda. Dr Nyombayire has extensive experience in the management of large infection diseases prevention programs (e.g. HIV, Ebola) involving most at risk populations and in collaboration with large external funding agencies
. He is currently the principal investigator of a large national HIV prevention program for Key and Priority Populations in Rwanda serving >100,000 at risk individuals every year. In addition to safety follow-up of participants enrolled in clinical trials, Dr Nyombayire is involved in the care and treatment of patients living with HIV and patients with symptoms of sexually transmitted infections (STIs) as part of his daily clinical duties.
Dr Nyombayire currently serves as the Executive Director of CFHR. He holds a degree of General Medicine and Surgery from the National University of Rwanda and a Master’s of Sciences degree in Clinical Trials from the London School of Hygiene and Tropical Medicine as well as several professional certifications in the management of clinical trials. He serves as a board member of the Rwanda National Research Ethics Committee and the University of Global Health Equity Institutional Review Board. He has also been a member of the Scientific Advisory Group for Marburg Disease Response during the 2024 MVD outbreak in Rwanda.
. He is currently the principal investigator of a large national HIV prevention program for Key and Priority Populations in Rwanda serving >100,000 at risk individuals every year. In addition to safety follow-up of participants enrolled in clinical trials, Dr Nyombayire is involved in the care and treatment of patients living with HIV and patients with symptoms of sexually transmitted infections (STIs) as part of his daily clinical duties.
Dr Nyombayire currently serves as the Executive Director of CFHR. He holds a degree of General Medicine and Surgery from the National University of Rwanda and a Master’s of Sciences degree in Clinical Trials from the London School of Hygiene and Tropical Medicine as well as several professional certifications in the management of clinical trials. He serves as a board member of the Rwanda National Research Ethics Committee and the University of Global Health Equity Institutional Review Board. He has also been a member of the Scientific Advisory Group for Marburg Disease Response during the 2024 MVD outbreak in Rwanda.
